
Biomarker-driven care is advancing in mantle cell lymphoma, though cost and infrastructure limit access in community oncology, according to a review.
Supplements and Featured Publications
about 26 years ago
Participating Facultyabout 26 years ago
Introductionabout 26 years ago
Clinician and Payer Issues in Managing Growth Hormone Deficiencyabout 26 years ago
CME / CPE / CCMCE Quizabout 26 years ago
Selected Abstracts





